Considering rationales for use in defining subgroups for the treatment of stimulant use disorder
- PMID: 33593678
- PMCID: PMC8026728
- DOI: 10.1016/j.drugalcdep.2021.108572
Considering rationales for use in defining subgroups for the treatment of stimulant use disorder
Conflict of interest statement
Comment in
-
Drug and Alcohol Dependence response to KK-21-1460 "Considering rationales for use in defining subgroups for the treatment of stimulant use disorder".Drug Alcohol Depend. 2021 Apr 1;221:108571. doi: 10.1016/j.drugalcdep.2021.108571. Epub 2021 Feb 4. Drug Alcohol Depend. 2021. PMID: 33597113 No abstract available.
Comment on
-
A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.Drug Alcohol Depend. 2020 Nov 1;216:108193. doi: 10.1016/j.drugalcdep.2020.108193. Epub 2020 Aug 1. Drug Alcohol Depend. 2020. PMID: 32861136 Free PMC article.
References
-
- World Drug Report 2018. (United Nations publication, Sales No. E.18.XI.9).
-
- Soares E, Pereira FC. Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups. Expert Opinion on Pharmacotherapy. 2019. December 12;20(18):2273–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
